| scholarly article | Q13442814 |
| P50 | author | Stephen S. Hecht | Q42174083 |
| Eric C. Donny | Q42409544 | ||
| Jennifer Tidey | Q60055546 | ||
| Joseph S Koopmeiners | Q86625843 | ||
| Dorothy Hatsukami | Q87445426 | ||
| Sarah S Dermody | Q87960941 | ||
| Mustafa al'Absi | Q89597003 | ||
| Neal L Benowitz | Q89685281 | ||
| Ryan Vandrey | Q96279772 | ||
| Rachel L Denlinger | Q114424565 | ||
| David J Drobes | Q114441386 | ||
| Andrew A Strasser | Q114441387 | ||
| P2093 | author name string | Sharon E Murphy | |
| Jason D Robinson | |||
| Paul M Cinciripini | |||
| Chap T Le | |||
| Steven G Carmella | |||
| F Joseph McClernon | |||
| Hilary Tindle | |||
| Maxine L Stitzer | |||
| Ivan D Montoya | |||
| Joni Jensen | |||
| Tonya Lane | |||
| P2860 | cites work | The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 |
| Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism | Q33723087 | ||
| Development of the Brief Wisconsin Inventory of Smoking Dependence Motives | Q33819601 | ||
| Metabolism and disposition kinetics of nicotine | Q34398241 | ||
| Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups | Q34434951 | ||
| Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents | Q34563489 | ||
| Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation | Q34621879 | ||
| Compensatory smoking from gradual and immediate reduction in cigarette nicotine content | Q35071508 | ||
| Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association | Q35573356 | ||
| Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes | Q35947187 | ||
| Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. | Q36047601 | ||
| Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation | Q36667391 | ||
| Reducing the nicotine content to make cigarettes less addictive | Q36786014 | ||
| Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale | Q36857832 | ||
| Reduced nicotine content cigarettes and nicotine patch | Q36927046 | ||
| Transient compensatory smoking in response to placebo cigarettes | Q37242430 | ||
| High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers | Q37243159 | ||
| Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure | Q37324677 | ||
| Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings | Q39420790 | ||
| Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany | Q39771327 | ||
| WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: third report of a WHO Study Group | Q42860648 | ||
| The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts | Q45144085 | ||
| Establishing a nicotine threshold for addiction. The implications for tobacco regulation | Q46058830 | ||
| Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette | Q46897472 | ||
| Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days | Q48418098 | ||
| Signs and symptoms of tobacco withdrawal | Q49016637 | ||
| Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man | Q77339862 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nicotine | Q12144 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1340-1349 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Randomized Trial of Reduced-Nicotine Standards for Cigarettes | |
| P478 | volume | 373 |
| Q89182956 | A Conceptual Framework for Understanding Multiple Tobacco Product Use and the Impact of Regulatory Action |
| Q34499623 | A Proposed Collaboration Against Big Tobacco: Common Ground Between the Vaping and Public Health Community in the United States. |
| Q37059838 | A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings |
| Q42723800 | A behavioral economic perspective on smoking persistence in serious mental illness |
| Q39396489 | A review of the effects of very low nicotine content cigarettes on behavioral and cognitive performance |
| Q91759485 | A review of tobacco regulatory science research on vulnerable populations |
| Q36254453 | A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol |
| Q47660489 | Abstinence-induced withdrawal severity among adolescent smokers with and without ADHD: disentangling effects of nicotine and smoking reinstatement |
| Q98244061 | Abuse Liability of Cigarettes with Very Low Nicotine Content in Pregnant Cigarette Smokers |
| Q61939936 | Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes |
| Q89928410 | Achieving Smoking Cessation Among Persons with Opioid Use Disorder |
| Q38612443 | Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction |
| Q40110624 | Adolescent Rats Self-Administer Less Nicotine Than Adults at Low Doses |
| Q88728504 | Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations |
| Q47161754 | Advances in Behavioral Laboratory Methods that Inform Tobacco Regulatory Science: A TCORS Working Group Special Issue |
| Q64966273 | Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial. |
| Q34554766 | Animal research on nicotine reduction: Current evidence and research gaps |
| Q92194023 | Anticipated Effects of Nicotine Reduction on Youth Smoking Initiation and Maintenance |
| Q89685288 | Applying tobacco, environmental and dietary-related biomarkers to understand cancer etiology and evaluate prevention strategies |
| Q38890394 | Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking |
| Q52311652 | Attrition during a randomized controlled trial of reduced nicotine content cigarettes as a proxy for understanding acceptability of nicotine product standards. |
| Q47786318 | Bayesian hierarchical modeling based on multisource exchangeability. |
| Q100696304 | Behavior change, health, and health disparities 2020: Some current challenges in tobacco control and regulatory science |
| Q38744516 | Behavioral Economic Laboratory Research in Tobacco Regulatory Science |
| Q92194100 | Behavioral Outcomes of Nicotine Reduction in Current Adult Smokers |
| Q92194061 | Behavioral and Subjective Effects of Reducing Nicotine in Cigarettes: A Cessation Commentary |
| Q38759887 | Behavioral change in response to a statewide tobacco tax increase and differences across socioeconomic status |
| Q64130688 | Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014) |
| Q97078442 | Biopsychosocial mechanisms associated with tobacco use in smokers with and without serious mental illness |
| Q49271444 | Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation |
| Q42810714 | Chemical, physical, and in vitro characterization of research cigarettes containing denicotinized tobacco |
| Q49694460 | Cigarette Design Features: Effects on Emission Levels, User Perception, and Behavior. |
| Q90331852 | Cigarette Management System: An operating procedures guide to obtaining and managing investigational tobacco products for regulatory science research |
| Q50204646 | Cigarette Nicotine Content as a Moderator of the Relationship Between Negative Affect and Smoking |
| Q47106790 | Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy |
| Q48873829 | Commentary on Nardone et al. (2016): Satisfaction, dissatisfaction and complicating the nicotine-reduction strategy with more nicotine |
| Q37349081 | Comparative risk assessment of tobacco smoke constituents using the margin of exposure approach: the neglected contribution of nicotine |
| Q97895199 | Comparing participant estimated demand intensity on the cigarette purchase task to consumption when usual-brand cigarettes were provided free |
| Q89825569 | Comparison of smoking cessation rates of Quitline users in Korea between smokers of ultra-low nicotine yield cigarettes and other types of cigarette: a prospective study |
| Q47729031 | Compensatory Puffing With Lower Nicotine Concentration E-liquids Increases Carbonyl Exposure in E-cigarette Aerosols. |
| Q58578907 | Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes |
| Q90286404 | Denicotinised cigarettes |
| Q90715939 | Differences in acute reinforcement across reduced nicotine content cigarettes |
| Q92578359 | Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers |
| Q57022949 | Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes? |
| Q45981734 | Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms. |
| Q92194108 | Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness |
| Q92194074 | Effects of Cigarette Nicotine Content and Menthol Preference on Perceived Health Risks, Subjective Ratings, and Carbon Monoxide Exposure Among Adolescent Smokers |
| Q92194121 | Effects of Framing Nicotine Reduction in Cigarettes on Anticipated Tobacco Product Use Intentions and Risk Perceptions Among US Adult Smokers |
| Q42418777 | Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine |
| Q92194017 | Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers |
| Q64984334 | Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence. |
| Q38729913 | Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. |
| Q52601399 | Estimation of compliance with exclusive smoking of very low nicotine content cigarettes using plasma cotinine. |
| Q46416161 | Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes. |
| Q38798057 | Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System |
| Q90650236 | Evaluation of Sex Differences in the Elasticity of Demand for Nicotine and Food in Rats |
| Q41640336 | Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use |
| Q92194141 | Examining Age as a Potential Moderator of Response to Reduced Nicotine Content Cigarettes in Vulnerable Populations |
| Q88541509 | Examining Risk Perceptions Among Daily Smokers Naïve to Reduced Nicotine Content Cigarettes |
| Q93013071 | Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate |
| Q91141575 | Examining the relationship between pregnancy and quitting use of tobacco products in a U.S. national sample of women of reproductive age |
| Q57173488 | FDA's regulatory shift on tobacco control |
| Q50091868 | Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. |
| Q57169581 | How Will Alcohol Research be Impacted by Future Reduction in Nicotine Content in Cigarettes? |
| Q90201090 | Impact of Brief Nicotine Messaging on Nicotine-Related Beliefs in a U.S. Sample |
| Q48301063 | Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial. |
| Q53813211 | Including Underrepresented Subgroups of Smokers in Tobacco Regulation Research. |
| Q47741829 | Increases in Cigarette Consumption and Decreases in Smoking Intensity when Non-Daily Smokers are Provided with Free Cigarettes |
| Q92194053 | Increasing Quit Attempts by Transitioning to Very Low Nicotine Content Cigarettes Versus Reducing Number of Cigarettes Per Day: A Secondary Analysis of an Exploratory Randomized Trial |
| Q92194043 | Interest in Illicit Purchase of Cigarettes Under a Very Low Nicotine Content Product Standard |
| Q89571918 | Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities |
| Q45946187 | Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy. |
| Q52310434 | Let actual markets help assess the worth of optional very-low-nicotine cigarettes before deciding on mandatory regulations. |
| Q46300070 | Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers |
| Q38779511 | Low nicotine content descriptors reduce perceived health risks and positive cigarette ratings in participants using very low nicotine content cigarettes |
| Q89259973 | Managing nicotine without smoke to save lives now: Evidence for harm minimization |
| Q57785682 | Modeling nicotine regulation: A review of studies in smokers with mental health conditions |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q89899565 | Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes |
| Q89259971 | Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation |
| Q92194172 | Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis |
| Q53622250 | Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes. |
| Q30244252 | Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research |
| Q64997227 | Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial. |
| Q58782319 | Patterns of Single and Multiple Tobacco Product Use Among US Women of Reproductive Age |
| Q38666342 | Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks |
| Q92194128 | Potential Moderating Effects of Psychiatric Diagnosis and Symptom Severity on Subjective and Behavioral Responses to Reduced Nicotine Content Cigarettes |
| Q30387434 | Potential sex differences in the pattern of sensory reinforcers enhanced by nicotine. |
| Q53632915 | Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers. |
| Q47291624 | Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content |
| Q47554864 | Public misperception that very low nicotine cigarettes are less carcinogenic. |
| Q37502340 | Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers' Urine by High Throughput Liquid Chromatography-Mass Spectrometry |
| Q90201054 | Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine |
| Q92991939 | Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations |
| Q41658014 | Reduced Nicotine Content Expectancies Affect Initial Responses to Smoking |
| Q47233701 | Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior |
| Q47957996 | Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial. |
| Q33868230 | Reduced nicotine content cigarettes in smokers of low socioeconomic status: study protocol for a randomized control trial |
| Q46067537 | Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game |
| Q39160675 | Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. |
| Q36120193 | Reduced-Nicotine Cigarettes--A Promising Regulatory Pathway |
| Q92194155 | Reducing Nicotine Without Misleading the Public: Descriptions of Cigarette Nicotine Level and Accuracy of Perceptions About Nicotine Content, Addictiveness, and Risk |
| Q46258132 | Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes |
| Q92194084 | Reducing the Nicotine Content of Cigarettes: Effects in Smokers With Mental Health Conditions and Socioeconomic Disadvantages |
| Q50061646 | Reducing the Prevalence of Smoking: Policy Measures and Focusing on Specific Populations |
| Q92194047 | Research on Behavioral Discrimination of Nicotine May Inform FDA Policy on Setting a Maximum Nicotine Content in Cigarettes |
| Q92345134 | Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status |
| Q88296476 | Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity |
| Q50354345 | Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects |
| Q47882543 | Sex differences in subjective responses to moderate versus very low nicotine content cigarettes |
| Q46133162 | Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. |
| Q90362354 | Shifting Frontiers in Basic Research on Nicotine and Tobacco Products |
| Q48034609 | Simulating demand for cigarettes among pregnant women: A Low-Risk method for studying vulnerable populations |
| Q41971019 | Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls |
| Q39404531 | Socioeconomic Disadvantage and Other Risk Factors for Using Higher-Nicotine/Tar-Yield (Regular Full-Flavor) Cigarettes |
| Q57171561 | Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science |
| Q57472093 | The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller |
| Q89899571 | The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial |
| Q92194115 | The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings |
| Q37695521 | The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use. |
| Q92194093 | The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes |
| Q92042926 | The Potential Impact of a Low Nicotine Product Standard for Cigarettes in Smokers Living With HIV |
| Q92194135 | The Role of Compensation in Nicotine Reduction |
| Q50790884 | The case for the WHO Advisory Note, Global Nicotine Reduction Strategy. |
| Q52313072 | The diverging trajectories of cannabis and tobacco policies in the United States: reasons and possible implications. |
| Q90448321 | The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats |
| Q90739504 | The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users |
| Q50455473 | Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers |
| Q36917735 | Threshold dose for discrimination of nicotine via cigarette smoking |
| Q52646286 | Tobacco and nicotine delivery product use in a U.S. national sample of women of reproductive age. |
| Q93228405 | Tobacco harm reduction: Past history, current controversies and a proposed approach for the future |
| Q88776566 | Treating Nicotine Dependence and Preventing Smoking Relapse in Cancer Patients |
| Q93031062 | US Food and Drug Administration considers comments on proposed nicotine product regulations: Some criticize the agency for not moving fast enough to stop youth e-cigarette use |
| Q38633358 | Use of higher-nicotine/tar-yield (regular full-flavor) cigarettes is associated with nicotine dependence and smoking during pregnancy among U.S. women |
| Q57380153 | Using Neuroscience to Inform Tobacco Control Policy |
| Q92194031 | Using Product Standards to Render the Most Harmful Tobacco Products Minimally Addictive: Maximum Nicotine Level, Non-Nicotine Constituents, and Scope |
| Q36971137 | Using eye-tracking to examine how embedding risk corrective statements improves cigarette risk beliefs: Implications for tobacco regulatory policy |
| Q51731739 | Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health. |
| Q58605679 | Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes |
Search more.